Search results for "DISORDERS"

showing 10 items of 4560 documents

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode ps…

2021

The work was supported by Guarantors of Brain post-doctoral clinical fellowship to DQ; Clinician Scientist Medical Research Council fellowship (project reference MR/M008436/1) to MDF; Heisenberg professorship from the German Research Founda- tion (grant no. 389624707) to UR; the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The EU-GEI Project is funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-…

medicine.medical_specialtyPsychosisPopulationNeurosciences. Biological psychiatry. NeuropsychiatryPHENOTYPESILLNESSPsychotic DisorderPredictive markersArticleCellular and Molecular NeuroscienceDEFICIT SYNDROMERisk FactorsFirst episode psychosismedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansCannabiClinical geneticsGenetic riskVALIDITYeducationSettore MED/25 - PsichiatriaSCHEDULEBiological PsychiatryMETAANALYSISCannabisUTILITYeducation.field_of_studyRisk FactorESQUIZOFRENIAASSOCIATIONCannabis usemedicine.diseaseBIFACTOR MODELPsychiatry and Mental healthPsychotic DisordersINTERRATER RELIABILITYSchizophreniaLinear ModelsSchizophreniaLinear ModelMedical geneticsPolygenic risk scorePsychologyHumanRC321-571Clinical psychology
researchProduct

ReMindCare, an app for daily clinical practice in patients with first episode psychosis: A pragmatic real-world study protocol.

2021

[EN] Aim Despite the potential benefits of e-health interventions for patients with psychosis, the integration of these applications into the clinical workflow and analysis of their long-term effects still face significant challenges. To address these issues, we developed the ReMindCare app. This app aims to improve the treatment quality for patients with psychosis. We chose to study the app in real world and pragmatic manner to ensure results will be generalizable. Methods This is a naturalistic empirical study of patients in a first episode of psychosis programme. The app was purpose-designed based on two previous studies, and it offers the following assessments: (a) three daily questions…

medicine.medical_specialtyPsychosismedia_common.quotation_subjectPsychological interventionIrritabilitysmartphoneMedication Adherence03 medical and health sciences0302 clinical medicineEmpirical researchmental disordersmedicineCIENCIAS DE LA COMPUTACION E INTELIGENCIA ARTIFICIALElectronic Health RecordsHumansadherencepsychosisPsychiatryappBiological Psychiatrymedia_commonFirst episodeE-healthbusiness.industryEarly Intervention in the Real Worldmedicine.diseasePsychosisMental healthMobile Applications030227 psychiatrySadnessPsychiatry and Mental healthPsychotic DisordersAdherenceAnxietye‐healthSmartphonePshychiatric Mental Healthmedicine.symptombusinessApp030217 neurology & neurosurgeryEarly intervention in psychiatry
researchProduct

Psychosis, Need Adapted treatment, and psychiatrists' agency

2013

Background: In the Need-Adapted approach (NAA) therapy meetings are a deliberate effort to bring all meaningful parties and views to a common discussion prior to decisions; this constitutes a challenge for psychiatrists’ agency. Aims: To describe how psychiatrists see their agency in NAA. Methods: Using videos of co-research interviews, stimulated-recall interviews of 10 interviewees were conducted and transcribed verbatim. The material was analyzed via an adapted dialogical-narrative analytical method. Results: Institutional forces were experienced as having an enormous impact on psychiatrists’ agency, especially in the inpatient setting, reducing professional creativity. In the outpatient…

medicine.medical_specialtyPsychosissisäinen dialogilääkärin toimijuusmedia_common.quotation_subjectbehavioral disciplines and activitiesinner dialoguepsychiatrists’ agencyAgency (sociology)mental disordersOutpatient settingmedicinepsychosisPsychiatryta515media_commonNeed-Adapted treatmentMedical educationTarpeenmukainen hoitoDialogical selfpsykoosiInpatient settingCreativitymedicine.diseaseHospital carePsychiatry and Mental healthPsychologyPsychosis: Psychological, Social and Integrative Approaches
researchProduct

Medications between psychiatric and addictive disorders

2016

International audience; Introduction : Many epidemiological studies have revealed a frequent co-occurrence of psychiatric and substance use disorders. The term used in the literature to refer to this co-occurrence is dual diagnosis. The high prevalence of dual diagnosis has led physicians to observe the effects of medication prescribed to treat psychiatric disorders on the co-occurring substance use disorder and vice versa. The concept of medications between psychiatric and addictive disorders stems from these clinical observations, alongside which, however, it has developed from the observation that both psychiatric and substance use disorders share common neurobiological pathways and trig…

medicine.medical_specialtyPsychotherapistSubstance-Related Disordersmedia_common.quotation_subject[SDV]Life Sciences [q-bio][ SDV.MHEP.PSM ] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthAddictionModafinilMirtazapine[ SCCO.PSYC ] Cognitive science/Psychology03 medical and health sciences0302 clinical medicineCognitionEpidemiology of child psychiatric disordersmedicineAnimalsHumansDual diagnosisMedical prescriptionPsychiatryClozapineBiological PsychiatryDepression (differential diagnoses)ComputingMilieux_MISCELLANEOUSmedia_commonPharmacologyPsychotropic DrugsDepressionAddictionmedicine.disease3. Good health030227 psychiatrySubstance abuseClinical researchSchizophreniaDiagnosis Dual (Psychiatry)[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health[SCCO.PSYC]Cognitive science/PsychologySchizophreniaDual diagnosisPsychologyPsychiatric disorders030217 neurology & neurosurgery
researchProduct

Psychoanalytically-Oriented Inpatient Psychotherapy of Somatoform Disorders

2008

Somatoform disorders have been neglected in psychoanalytic publications. Unlike the descriptive approach of DSM-IV and ICD-10, sophisticated psychoanalytical models have been proposed for many years explaining the development of physical symptoms without definable medical cause. Based on a review of the psychoanalytic models of somatization and conversion, this article explores difficulties in the medical and psychotherapeutic treatments of somatoform disorders. The unique tradition of psychosomatic inpatient treatment in Germany is illustrated by the psychoanalytic treatment setting at the University of Mainz. A case report of a somatoform patient shows how childhood trauma is activated an…

medicine.medical_specialtyPsychotherapistmedicine.medical_treatmentArt therapyModels PsychologicalGroup psychotherapyGermanymedicineHumansPsychoanalytic theorySomatoform DisordersPsychiatryAgedDefense MechanismsDance TherapySocial environmentMultimodal therapyGeneral Medicinemedicine.diseasePsychoanalytic TherapyHospitalizationPsychiatry and Mental healthClinical PsychologyMentalizationChronic DiseaseWorking throughFemalePsychologySomatizationThe Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry
researchProduct

Manualized psychodynamic-interactional group therapy for the treatment of somatoform pain disorders.

2010

Medically unexplained and clinically significant symptoms of pain are highly prevalent in the general population. More than one third of all patients in general practices and various departments of hospitals suffer from somatoform disorders with pain being the main complaint of 70% of these patients. This treatment manual is the first disorder-specific, psychodynamically oriented treatment for these patients. Based on psychodynamic-interactional group psychotherapy, it focuses on disorder-specific aspects as well as on psychic and interpersonal problems which have resulted from adverse childhood experiences and insecure attachment. In three treatment phases comprising an “information and mo…

medicine.medical_specialtyPsychotherapistmedicine.medical_treatmentTransfer PsychologyPopulationPsychological interventionMEDLINEPainGroup psychotherapyLife Change EventsMind-Body Relations MetaphysicalInterpersonal relationshipManuals as TopicPatient Education as TopicmedicineHumansPain ManagementAffective SymptomsAdverse Childhood ExperienceseducationPsychiatrySomatoform Disorderseducation.field_of_studyCommunicationPsychodynamicsSocial relationPsychoanalytic TherapyPsychiatry and Mental healthClinical PsychologyTreatment OutcomeChronic DiseasePsychotherapy GroupPshychiatric Mental HealthPsychologyArousalBulletin of the Menninger Clinic
researchProduct

A common role for psychotropic medications: memory impairment.

2002

Summary The psychopathologic profile of mental disorders is very diverse and psychotropic medications used to treat them differ in their chemical structure. Nevertheless, these drugs share these four characteristics: delayed onset of clinical response, not one of them can be said to cure, there is a high number of non-responders, and the mechanism responsible for their therapeutic action is not known. It is hypothesized that the action of psychotropic medications is memory impairment, understanding memory as the trace left in the nervous system not only by individual experiences but also by genetic and epigenetic phenomena. It is suggested that it would be beneficial to translate some resea…

medicine.medical_specialtyPsychotropic DrugsTherapeutic actionMechanism (biology)Mental DisordersDelayed onsetBrainGeneral MedicineModels PsychologicalAntidepressive AgentsAction (philosophy)Research strategiesMemorymedicineCyclic AMPMemory impairmentHumansPsychologyPsychiatryClinical psychologyAntipsychotic AgentsSignal TransductionMedical hypotheses
researchProduct

Transesophageal Echocardiography - Dysphagia Risk in Acute Stroke (TEDRAS): a prospective, blind, randomized and controlled clinical trial.

2020

BACKGROUND AND PURPOSE Dysphagia is common in acute stroke and leads to worse overall outcome. Transesophageal echocardiography (TEE) is used in the diagnostic evaluation of stroke with regard to its etiology and is a known cause of postoperative dysphagia in cardiac surgery. The prevalence of dysphagia in acute stroke patients undergoing TEE remains unknown. The aim of the Transesophageal Echocardiography - Dysphagia Risk in Acute Stroke (TEDRAS) study was to assess the influence of TEE on swallowing among patients who have experienced acute stroke. METHODS The TEDRAS study was a prospective, blind, randomized, controlled trial that included two groups of patients with acute stroke. Simple…

medicine.medical_specialtyRandomizationlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialSwallowinglawMedicineHumans030212 general & internal medicineProspective StudiesStrokebusiness.industrymedicine.diseaseDysphagiaCardiac surgeryDeglutitionClinical trialStrokeNeurologyAnesthesiaEtiologyNeurology (clinical)medicine.symptombusinessDeglutition Disordershuman activities030217 neurology & neurosurgeryEchocardiography TransesophagealEuropean journal of neurologyReferences
researchProduct

Is arthrocentesis of temporomandibular joint with corticosteroids beneficial? A systematic review

2018

Background Temporomandibular disorders (TMDs) are musculoskeletal conditions that can inhibit the normal function of temporomandibular joints (TMJs) and affect the patient’s quality of life, negatively. Arthrocentesis (AC) is a minimally invasive surgical procedure used for treating TMDs. The aim of present paper is to evaluate the advantages of administrating corticosteroid (CS) during AC by reviewing high quality released articles. Material and Methods Searching on Cochrane Library, Web of Science, Google Scholar, PubMed, ProQuest, and Scopus databases were performed with focusing on proper key words. Related titles and abstracts, up to December 2017, were screened and selected based on i…

medicine.medical_specialtyRandomizationmedicine.medical_treatmentMEDLINEPain reliefReviewCochrane Librarylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialQuality of lifestomatognathic systemlawmedicineHumans030212 general & internal medicineGlucocorticoidsGeneral DentistryRandomized Controlled Trials as Topicbusiness.industryArthrocentesis030206 dentistryTemporomandibular Joint Disorders:CIENCIAS MÉDICAS [UNESCO]Combined Modality TherapyTemporomandibular jointstomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASPhysical therapySurgeryOral SurgerybusinessArthrocentesis
researchProduct

The use of the Free Recall Method in the Analysis of Verbal Memory Deficits in Dual Diagnosis Patients

2009

In schizophrenia there are specific cognitive deficits including verbal memory deficits. The objective of this study was to examine short-term verbal memory differences between subjects with and without a dual diagnosis.A group of 80 patients with a diagnose of schizophrenia were examined. 40 of them never used illicit drugs, the other 40 also received a diagnose of addiction to psychoactive substances. The Free Recall Method was used to compare two examined groups. The results of addicted and not addicted schizophrenic patients were analyzed in all trials of the 5 stages of the examination with the use of Free Recall Method. Persons suffering from schizophrenia can usually repeat much fewe…

medicine.medical_specialtyRehabilitationCalifornia Verbal Learning TestAddictionmedia_common.quotation_subjectmedicine.medical_treatmentCognitionmedicine.diseasePsychiatry and Mental healthFree recallSchizophreniamental disordersmedicineDual diagnosisVerbal memoryPsychiatryPsychologymedia_commonClinical psychologyEuropean Psychiatry
researchProduct